VENTAC PARTNERS IS A DEDICATED LIFE SCIENCE CONSULTING FIRM WITH OFFICES IN EUROPE, USA AND ASIA.

Ventac Partners has a strong track record in founding new innovative companies, strategic and operational market and product analysis, intellectual property development, fund raising, licensing, M&A and strategy consulting.

All partners are experienced executives from pharma, biotech and medtech companies, and preclinical, clinical and regulatory, legal and intellectual property experts with extensive backgrounds in successfully starting, growing and expanding international life science companies.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Latest News
April, 2012 | APIM Therapeutics, a VP portfolio company, featured as  "Emerging Company" by leading biotechnology journal, Biocentury.

February, 2012 | Casigen Pharma is a Hong Kong based company focusing on the development of novel therapeutic compounds for metabolic disease indications.

January, 2012 | Avexxin closes series A financing round enabling the company to advance its lead compound forward through clinical trial phase I/IIa.

December, 2011 | Mikael Oerum appointed to the Scientific Advisory Board of Virginia Bioinformatics Institute at Virginia Tech, USA.

Announcements
Human Genetic and Society Cover
Ahram Biosystems goes to the head of the class with mention of its Palm PCR™ system in Human Genetics and Society; a science textbook for US college students.

More Information